Is the shift toward "first-line immunotherapy" finally...

Ajouter une nouvelle offre d'emploi Health

2026-01-29 12:08:36 -

Is the shift toward "first-line immunotherapy" finally changing the survival outlook for esophageal cancer?

For years, a diagnosis of advanced esophageal squamous cell carcinoma (ESCC) came with limited options, mostly centered around traditional chemotherapy. However, the esophageal squamous cell carcinoma market is currently witnessing a massive transformation as immunotherapy moves into the first-line treatment setting. New checkpoint inhibitors, such as those targeting the PD-1 pathway, are being...

0 Commentaires 0 Parts 55 Vue 0 Aperçu